Metazoan internal organs are assembled from polarized tubular epithelia that must set aside an apical membrane domain as a lumenal surface. In a global Caenorhabditis elegans tubulogenesis screen, interference with several distinct fatty-acid-biosynthetic enzymes transformed a contiguous central intestinal lumen into multiple ectopic lumens. We show that multiple-lumen formation is caused by apicobasal polarity conversion, and demonstrate that in situ modulation of lipid biosynthesis is sufficient to reversibly switch apical domain identities on growing membranes of single post-mitotic cells, shifting lumen positions. Follow-on targeted lipid-biosynthesis pathway screens and functional genetic assays were designed to identify a putative single causative lipid species. They demonstrate that fatty-acid biosynthesis affects polarity through sphingolipid synthesis, and reveal ceramide glucosyltransferases (CGTs) as end-point biosynthetic enzymes in this pathway. Our findings identify glycosphingolipids, CGT products and obligate membrane lipids, as critical determinants of in vivo polarity and indicate that they sort new components to the expanding apical membrane.
has not yet been demonstrated [16] [17] [18] . Studies are furthermore limited by uncertain effects of toxins and lipids used for the in vitro analysis of sphingolipids. Moreover, GSL-biosynthetic-enzyme knockouts, although demonstrating an essential GSL role in vivo, failed to confirm a polarity function 19 . The ability of GSLs to generate polarized plasma membrane domains is therefore uncertain and their essential role in development is unknown.
Here, a global C. elegans tubulogenesis screen, followed by targeted lipid-biosynthetic pathway screens, identifies GSLs, the CGT products, as a lipid species, whose loss, along with each of ten of its upstream biosynthetic enzymes, displaces apical domains on expanding membranes, generating multiple intestinal lumens. An unbiased genetic morphogenesis screen thus identifies a membrane lipid with an apical sorting function in mammalian cell lines as an apical domain identity cue during de novo membrane biogenesis of invertebrate tubular epithelia.
RESULTS

Interference with four distinct lipid-biosynthetic enzymes converts apicobasal polarity, generating lateral lumens
To examine tubulogenesis and lumen formation, a visual RNA interference (RNAi) screen was carried out using C. elegans engineered with ERM-1::GFP-labelled lumenal membranes (Methods). RNAi with all chromosome III genes (N = 2,278) revealed that most (>90%) informative phenotypes involved essential genes, to which further genome screening was then restricted. A highly penetrant intestinal polarity phenotype ( Fig. 1a) was identified by knockdowns of each of four different lipid-biosynthetic enzymes: POD-2, an acetylCoA carboxylase; LET-767, a steroid dehydrogenase/3-ketoacyl-CoA reductase; ACS-1, a long-chain-fatty-acid (LCFA)-acyl-CoA ligase; and SPTL-1, a serine palmitoyltransferase (SPT). Single-cell analysis of intestinal tubulogenesis revealed the same sequence of events in all: in either late-stage embryos (pod-2(RNAi)) or first-stage larvae (L1; let-767, acs-1-and sptl-1(RNAi), their respective arrest stages) ERM-1::GFP was gradually lost from the apical membrane while appearing at basolateral membranes; lateral membranes transformed into ring structures; initially contiguous central apical ERM-1::GFP fractionated into non-contiguous lateral openings, indicating that multiple lateral ectopic lumens may be present ( Fig. 1b and Supplementary Fig. S1a,b) . Digestive tract morphogenesis appeared otherwise unaffected and the epithelium intact ( Supplementary Fig. S2 ). Additional apical submembraneous and integral membrane proteins were all similarly displaced to lateral membranes or the cytoplasm, including cortical actin and the apical Par (partitioning-defective) ICB4 stains an unknown panmembraneous marker in wild type (wt); apicobasolateral ERM-1/ICB4 overlay (turquoise, arrow) in early-stage mutant (RNAi) phenotype (mt); ICB4 subapical accumulation (blue, arrow) in late-stage mutant; same image with separated ICB4 for clarity. (g) NHX-7, a basolateral integral membrane Na + /H + pump, retained at basolateral membranes, but partially cytoplasmically displaced in late-stage mutant. (h) Basolateral LET-413, a junction-mediated polarity determinant 59 , excluded from apical membrane in wild type (no IFB2 overlap) and also from lateralized ectopic lumenal membrane in mutant, but not displaced from the basolateral membrane (arrow). (i,j) Apical junctions. The junction integrity molecule AJM-1 and the adherens junction component HMP-1 remain contiguous at apicolateral boundaries in both wild type and mutant (arrowheads), but additionally surround nascent lateral lumens in mutant (arrows; note absence of fragmented junction pattern). (k) Feeding of dsRed-labelled bacteria fails to label ectopic lumens (arrows) or the cytoplasm of mt (same sections in all). Confocal images of representative L1 intestinal sections are shown: pod-2-, let-767-, acs-1-and sptl-1 RNAi cause the same mislocalization/localization of all markers (N > 40 for each marker). -polarity-complex component PAR-6. Basolateral molecules, including the polarity determinant LET-413 (the Scribble homologue), were less affected, although partially displaced subapically (Fig. 2a-h and Supplementary Fig. S3a-d ). Transmission electron microscopy (TEM) revealed corresponding structural conversions of apical and basolateral domains: microvilli and the submembraneous terminal web were lost apically and acquired laterally, identifying lateral openings as true lumens rather than membrane adhesion defects or intracellular vacuoles (Fig. 1c,d and Supplementary Figs S1c and S3h). Apicobasal polarity defects of developing epithelia have been characterized as polarity loss through membrane equilibration and as unilateral, typically apical, domain expansion; both changes generally caused by apical junction defects 3, 7 . In contrast, we find polarity conversion: apical characteristics are coincidentally lost from the original apical, and gained by the original lateral domain. In further contrast, intestines lacked typical apical junction defects 20 : loss, fragmentation or displacement of AJM-1, HMP-1 (the α-catenin homologue) and DLG-1 (the Discs-large homologue) from apicolateral junctures; ultrastructural defects at apicolateral sealing positions; and label uptake from fluorescently labelled bacterial food into intercellular spaces. Conversely, after polarity conversion but before single lateral lumen formation, additional junctions formed between nascent lateral lumens, indicating that they may contribute to de novo apical domain biogenesis on the lateral side rather than reflecting an assembly defect preceding and causing the polarity alteration (Figs 1c and 2i-k and Supplementary Fig. S3e-h) .
We conclude that interference with any one of four distinct lipid-biosynthetic enzymes converts intestinal apicobasal membrane domain identities, generating separate lateral lumens. Germline mutations in fatty-acid-biosynthetic enzymes cause intestinal tubulogenesis defects that are rescued with exogenous fatty acids. An allelic series of let-767 point mutations 26 includes: s2176 , suggested null (early larval lethality); s2819 , moderately severe (mid-larval lethality); and s2464, less severe allele (reaches adulthood with lethal progeny (maternal-effect)). (a) Top, confocal image of s2819 with early basolateral ERM-1::GFP displacement; bottom, s2176 with early ectopic lumen formation (let-767(s2167/s2819) dpy-17(e164) unc-32(e189)III; sDp3(III;f); fgEx13(perm-1::erm-1::gfp rol-6(su1006))). Lateral ERM-1::GFP displacement and ectopic lumen formation are obscured in the Dpy background with widened intestinal lumen and body shape. (b) Penetrance and expressivity of tubulogenesis defects (speed of development and number and size of lateral lumens) increase with allelic severity. Higher penetrance by RNAi than in s2176 indicates maternal product requirement. All animals were evaluated 30 h post-hatching. Mean±s.d. shown, n = 5 (N > 200 animals per experiment) for mutants and n = 5 (N > 1,000 animals per experiment) for RNAi animals. (c) Rescue with exogenous lipids supplied by food. mmBCFAs partially rescue let-767 -, fully rescue acs-1-, but not pod-2(RNAi) tubulogenesis defects; straight-chain LCFAs partially rescue let-767-, fully rescue pod-2-, but not acs-1(RNAi). sptl-1(RNAi) defects are not rescued with either mmBCFAs or straight-chain LCFAs. Experimental and control animals were evaluated 60 h post-feeding with fatty acids/solvents (Methods). Mean ± s.d. is shown, n = 5 (N > 200 animals per experiment), * P < 0.05 and * * * P < 0.001, two-tailed t -test. (d) Top, moderately severe let-767(s2819) allele (later stage of phenotype development than in a); bottom, almost fully rescued with exogenous mmBCFAs.
Lipid-biosynthetic enzymes affect apical sorting during de novo membrane biogenesis C. elegans intestinal cell division, migration and intercalation are complete at mid-embryogenesis. To determine whether the late-embryonic or larval polarity changes reflected a role of lipid-biosynthetic enzymes in polarity maintenance rather than establishment, enzymes were RNAi-inactivated post-embryogenesis (Methods). This was sufficient to displace ERM-1::GFP basolaterally and switch lumen position in the mature larval, but not adult, epithelium ( Supplementary Fig. S4a ). Lipid-biosynthetic enzymes thus maintain post-mitotic intestinal polarity, but only in larvae, not in adults (a potential early embryonic requirement, for example through maternal lipids, cannot be excluded).
The morphogenetic feature distinguishing larval from adult intestines is net growth 21 , indicating that the polarity function of lipid-biosynthetic enzymes may be linked to epithelial expansion. Consistent with this, full polarity conversion, although confined to one stage (the arrest stage, late embryo or L1), required an extended period of time where animals grow (∼two days at 20
• C; Fig. 3a) . Notably, growth suppression through food deprivation 22 attenuated it, indicating that membrane expansion was required to manifest the polarity change ( Supplementary Fig. S4b,c) . To explore the role of lipid-biosynthetic enzymes in de novo polarized membrane biogenesis, we searched for a newly apically delivered polarized molecule that was laterally displaced on lipid-biosynthesis perturbations. ERM-1::GFP recovery after erm-1(RNAi) removal revealed that ERM-1 is continuously supplied to larval, but not adult, lumenal membranes (peak delivery in L1 larvae; Supplementary Fig. S5 ). As ERM-1::GFP is displaced from expanding, but not non-expanding (starved) larval or adult membranes, these enzymes must target new components to the apical membrane during its biogenesis.
If lipid-biosynthetic enzymes maintain polarity by sorting newly synthesized membrane components, the effect of their loss might be reversible. To investigate this, their activity was restored in enzymedepleted RNAi larvae with ectopic lumens. Strikingly, lipid-biosynthesis reactivation reversed apical membrane lateralization, closed lateral lumens, rebuilt a contiguous central lumen and rescued growth-arrest and lethality ( Fig. 3b and Supplementary Fig. S4b -d for comparison with Dauer-dependent arrest reversal).
We conclude that specific components of lipid biosynthesis are required to sort apical molecules during de novo membrane biogenesis, sustaining apicobasal domain identities and a contiguous lumen in C. elegans intestinal epithelia.
Polarized membrane biogenesis requires saturated long-chain-fatty-acid biosynthesis
We considered that pod-2-, let-767-, acs-1-and sptl-1(RNAi)-induced polarity defects might result from the loss of a common single lipid product, although these enzymes were not components of an obvious biosynthetic pathway. We first examined POD-2, LET-767 and ACS-1, all biochemically defined fatty-acid-biosynthetic enzymes with intestinal localization [23] [24] [25] . Knockdowns were validated as specific and severe losses-of-functions by confirming ERM-1::GFP displacement in pod-2(ye60) intestines 25 (not shown) and demonstrating increasing polarity and tubulogenesis defects in an allelic series of let-767 loss-of-function mutants 26 ( Fig. 4a,b) . Disrupting biosynthetic pathways increases upstream substrates while decreasing downstream products. It was thus unlikely that toxic intermediates would induce polarity defects generated by losing different enzymes, including one catalysing the first committed step in de novo lipid biosynthesis (POD-2). Confirming this, exogenous fatty acids rescued the phenotype, in addition to the previously demonstrated wild-type gene rescue 23, 25 ( Fig. 4c,d ). This result also excluded non-lipid-related dual enzyme functions and supported the assumption that losing one or more lipid compounds generated the phenotype.
Next, we knocked down 162 genes known or predicted to contribute to fatty-acid biosynthesis, metabolism or transport. Animals were examined for tubular polarity defects and negative results were Figure 5 Tubular polarity requires saturated LCFA biosynthesis. Conserved fatty-acid-biosynthesis pathways are shown 56 . POD-2 and FASN-1 catalyse the first steps in saturated small-and medium-chain-fatty-acid biosynthesis (top: acetyl-CoA shown as primer example for even-numbered SFAs, isovaleryl-CoA for odd-numbered mmBCFAs), subsequently elongated to LCFAs by elongases (middle: this area was probed in greater detail and has been expanded; see text), variably desaturated by desaturases (right). All products are precursors for complex lipids (bottom). The presence or absence of polarity defects (wild-type (wt) or mutant (mt) indicated throughout by image insets) was evaluated in RNAi animals and/or germline mutants (see Supplementary Table S1 for specific genes targeted (N = 162), most of which lacked polarity defects; see Supplementary Fig. S6 for phenotypes). Identified enzymes are shown in blue, and corresponding genes are shown in red. fasn-1(RNAi) was not identified here because of its early arrest (pod-2 and fasn-1 are the only lipid-biosynthetic enzymes previously shown to affect polarity, at the first-cell stage; the mediating lipid compound was not identified 25 ). The precise pathway location of acs-1 is not known. Decreasing cholesterol levels to trace amounts did not produce the phenotype (not shown; C. elegans is a cholesterol auxotroph, but requires such low amounts of cholesterol that its role as a structural membrane lipid has been questioned 60 ).
confirmed in selected germline mutants at pathway branch points ( Fig. 5 and Supplementary Table S1 ). One additional enzyme was identified: ELO-3, an elongase predicted to generate LCFAs ( Fig. 5 and Supplementary Fig. S6a ). The identification of ELO-3 supported those of POD-2, LET-767 and ACS-1, with POD-2 catalysing the first step synthesizing short-and medium-length saturated fatty acids (SFAs; LCFA building blocks) and the others directly contributing to LCFA biosynthesis of straight or monomethyl branched-chain fatty acids 23, 24, 27 (mmBCFAs). As elongases condense fatty acids to ketoacyl-CoA, we reasoned that ELO-3 might generate the substrate for the 3-ketoacyl-CoA reductase LET-767. To examine the enzymatic step downstream of this reductase we searched the C. elegans genome for an orthologue predicted to use the LET-767 product 3-hydroxy-acyl-CoA as a substrate and identified 3-hydroxyacyl-CoA dehydratase homology in the PTP-like protein T15B7.2. Its knockdown copied the phenotype ( Fig. 5 and Supplementary Fig. S6b ), indicating that ELO-3, LET-767 and T15B7.2 catalyse consecutive steps in the biosynthesis of the presumed polarity-affecting lipid.
In contrast, desaturase gene knockdowns did not generate the polarity defect. Desaturases synthesize mono-and polyunsaturated fatty acids 28, 29 (MUFAs and PUFAs). This negative result was confirmed in the non-redundant strong loss-of-function allele fat-2(wa17) that lacks normal PUFAs (ref. 29 ; Fig. 5 , not shown), although not additionally confirmed in germline mutants of redundant MUFA desaturases 28 . We conclude that a putative common lipid species should contain saturated LCFAs, possibly MUFAs, probably mmBCFAs, but not PUFAs, excluding many lipid-signalling molecules and phosphoinositides as candidates for this specific polarity function.
Saturated LCFA biosynthesis determines polarity through sphingolipid synthesis
We next examined the fourth identified enzyme, SPTL-1, predicted to condense a fatty acid with serine to form the long-chain-base (LCB) sphinganine as the first committed step in de novo sphingolipid synthesis (Figs 6a and 7a). As expected, fatty acids did not rescue its RNAi phenotype (Fig. 4c) . The role of sphingolipid in polarity was, however, confirmed through sptl-1(RNAi) phenocopy by: double knockdowns of sptl-2 and sptl-3, two additional C. elegans SPTs ( Supplementary Fig. S6e ); and feeding myriocin or fumonisin B, mycotoxins specifically inhibiting SPT and ceramide synthase, respectively. Both inhibitors dose-dependently induced the phenotype ( Fig. 7a and Supplementary Fig. S6c ). As ceramide synthase generates ceramide from sphinganine, we infer that sphinganine itself, previously suggested to affect polarity in hepatoma cell lines 30 , is excluded here because both sphinganine loss (through myriocin and sptl-1(RNAi)) and excess (through fumonisin) generate the phenotype.
Ceramide (Cer), the building block of all complex sphingolipids, contains a second LCFA in addition to the one used for the LCB (Fig. 6a ). Sphingolipid synthesis is thus strictly dependent on LCFAs, generally SFAs, and, in C. elegans, mmBCFAs (ref. 31 ), but not PUFAs, making sphingolipids good candidates for the putative common lipid compound. A series of experiments supported this idea. First, pod-2-, acs-1-and let-767(RNAi) phenotypes failed to efficiently reverse when sphingolipid synthesis was inhibited (Fig. 6b) . Second, mild sptl-1-, pod-2-and acs-1(RNAi) enhanced moderate let-767 alleles (not shown) and were themselves dominantly enhanced by let-767(s2819);sDp3 (Fig. 6c) . Third, mass spectrometry profiles of selected sphingolipids showed similar decreases in let-767-, acs-1-and sptl-1(RNAi) animals ( Table S3 ). These profiles also confirmed that C. elegans sphingolipids use C17 mmBCFAs for the LCB (ref. 31) , and demonstrated that saturated LCFAs are used for the ceramide. Finally, exogenous sphingolipids partially rescued the polarity phenotype of animals deficient for fatty-acid-biosynthetic enzymes (see below).
We conclude that pod-2, let-767, acs-1, elo-3 and T15B7.2 are C. elegans sphingolipid-biosynthesis pathway components, and as such they are required for tubular polarity. We also note that the essential but unknown mmBCFA function 27 at least partially results from it contributing to polarity and tubulogenesis through sphingolipid synthesis. Table S3) . Bars indicate median; wild type arbitrarily set at 1; dots represent individual compounds. Concentrations calculated from the mass-spectrometry-derived response ratio of compound area/internal standard area of the corresponding period per sample dry weight.
Polarity depends on ceramide glucosyltransferases
To identify the putative common polarity-affecting sphingolipid species, we knocked down 85 genes predicted to contribute to complex lipid and sphingolipid metabolism and regulation, adding double and triple RNAi and RNAi-sensitive conditions to detect redundant enzymes and mild effects (Fig. 7a and Supplementary Table  S2 , Methods). The phenotype was found in the single knockdown of a predicted sphingolipid fatty-acid hydroxylase, C25A1.5, and the double knockdown of the CGT orthologues cgt-1 and cgt-3 ( Supplementary Fig. S6d ,f). CGTs generate only glucosylceramide (GlcCer), the GSL backbone 17 , and, in contrast to the previously identified enzymes, do not produce substrates for the biosynthesis of multiple lipids. This result therefore identifies GSLs as the furthest downstream polarity-affecting lipid species, and indicates that their loss generates the polarity defects induced by its ten upstream lipid-biosynthetic enzymes. 56 . Left, de novo biosynthesis; right, salvage pathway; bottom, complex membrane sphingolipid biosynthesis. Presence/absence of polarity defects were assessed in RNAi animals and/or germline mutants (see Supplementary Table S2 for specific genes targeted (N = 85), most of which lacked polarity defects; see Supplementary Fig. S6 for phenotypes). Identified enzymes are shown in blue, and corresponding genes are shown in red. The precise location of sphingolipid fatty-acid hydroxylase is unknown. (b) sptl-1-, cgt-1(tm999);cgt-3-and let-767(RNAi) tubulogenesis defects are partially rescued by exogenous sphingolipids. A sphingolipid standard mixture, containing ten different sphingolipid compounds, was fed with RNAi bacteria (Methods). The percentage of animals with tubulogenesis defects was evaluated 64-66 h after feeding with lipids or solvents (control). Mean±s.d. is shown, n = 5 (N > 200 animals per experiment), * P < 0.05, two-tailed t -test. (c) NBD-C6-GlcCer (NBD-GSL) supplementation attenuates ectopic lumen formation in sptl-1-, let-767-and cgt-1(tm999);cgt-3-(RNAi) L1 intestines. Animals were evaluated for 'severe' (discontinuous central lumen/large ectopic lumens) versus 'mild' (partially contiguous central lumen/small ectopic lumens) phenotypes 5 and 6 days after feeding with GSLs or solvents (control; supplied with RNAi bacteria). For sptl-1 RNAi, which induces the strongest phenotype, 'severe' was defined as arrest/intestinal disintegration and 'mild' as mobile/intestine not disintegrated. Confocal microscopy sections of representative animals are shown. Mean ± s.d., n = 5 (N > 200 animals per experiment), * P < 0.05, two-tailed t -test. (d) The arthro-series of GlcCer derivatives is dispensable for the function of GlcCer in tubular polarity. The first steps of insect-type GlcCer-derivative biosynthesis are shown, and corresponding C. elegans orthologues are on the left 39 . The inset demonstrates intact intestinal lumen (purple) in the presumed null allele bre-3(ye28) combined with bre-3(RNAi) (animals grow to fertile adults) 39 . N > 2, 000. (e) Accumulated mass spectra of wild-type GlcCer-OH with an elution peak of 6.27 min (Fig. 6d) . GlcCer with m/z 787.2, with a C17 sphingoid base and a hydroxylated saturated C22 fatty-acid chain, was present in greatest abundance (inset). Several findings further supported the role of CGTs and GSLs in tubular polarity. Previous studies determined that: C. elegans CGTs are expressed and function cell-autonomously in the intestine; they synthesize GSLs in vitro and in vivo; and arrested cgt-1,ctg-3-double and cgt-1,ctg-2,ctg -3-triple RNAi/mutant larvae have decreased although not absent GSL levels [32] [33] [34] [35] . We found the polarity phenotype in double cgt-1(tm999);cgt-3(tm504) mutants, different combinations of cgt-1,cgt-3-double mutant/RNAi animals and in animals fed with the CGT inhibitor d,l-threo-PDMP ( Supplementary Fig. S6f ,g, not shown; Methods). Although complex membrane lipids may not be expected to recapitulate their endogenous roles as end products on membranes 36 (in contrast, exogenous fatty acids can function as metabolic intermediates or signalling molecules 24, 25 ; compare Fig. 4c,d ), exogenous labelled and unlabelled sphingolipids were tested for rescue. Neither we nor others could rescue cgt-1;cgt-3-double-mutant/RNAi-induced lethality with exogenous GSLs (ref. 34); however, feeding a mixture of synthetic sphingolipids (including GSLs), made to human templates, mildly improved ctg-1(tm999);ctg-3(RNAi) tubulogenesis defects, and NBD-C6-GlcCer uptake attenuated their severity (Fig. 7b,c) .
A R T I C L E S
Without excluding other possible sphingolipid contributions, additional results indicated that GSLs mediate the polarity effect of their upstream fatty-acid-and sphingolipid-biosynthetic enzymes: moderate cgt-;cgt-3(RNAi) polarity phenotypes were dominantly enhanced by let-767(s2819);sDp3 (Fig. 6c) ; ctg-1(tm999);ctg-(RNAi)-rescuing sphingolipids and GSLs likewise partially rescued let-767(RNAi) and sptl-1(RNAi) tubulogenesis defects that were similarly attenuated by NBD-C6-GlcCer (Fig. 7b,c) ; mass spectrometry profiles showed comparable GSL losses in fatty-acid-and sphingolipid-biosynthesisdefective animals ( Supplementary Fig. S7a and Table S3 ). Of note, the complex membrane sphingolipids GSL and sphingomyelin ratio was consistently altered, with a greater loss of GSLs, indicating a corresponding change in membrane lipid composition ( Supplementary Fig. S7b ).
We conclude that the furthest downstream lipid-biosynthetic pathway enzyme CGT, and its product GlcCer, are required for tubular polarity, indicating that GSLs are the polarity-affecting common lipid species.
Polarity requires hydroxylated GlcCer, whereas further sugar modifications are dispensable
GSLs could affect polarity through GlcCer intermediates, derivatives or GlcCer itself. The systematic approach of the pathway screen largely excludes the first: gaining and losing multiple different intermediates of eleven GSL-biosynthetic enzymes equally disturbs polarity. This includes ceramide, the immediate metabolite of GlcCer (single and double RNAi of glucocerebrosidases also failed to generate the phenotype, although multiple-null mutants were not tested; Supplementary Table S2) . As GSL metabolism occurs on endomembranes 37 , it cannot, however, be excluded that they function through an organelle-sequestered intermediate subfraction.
Further sugar modifications of the GlcCer backbone create the large GSL family 38 . Single knockdowns of 112 gene candidates for the biosynthesis or function of GlcCer derivatives (Supplementary  Table S4 ), including those previously ordered into a biosynthetic pathway for insect-specific derivatives 39 , failed to generate the polarity phenotype. bre-3(ye26 ), a viable, presumed null allele for a β4-mannosyltransferase that catalyses the first step in their biosynthesis, confirmed these negative results, excluding the arthro-series of GlcCer-derivatives as required for this function (Fig. 7d) .
Our mass spectrometry profile furthermore revealed the complete absence of lactosylceramide and consequently the entire GSL lactoseries ( Supplementary Fig. S7c,d ), supporting previous assumptions that C. elegans, similarly to Drosophila, exclusively uses the arthro-series of GlcCer derivatives 39, 40 . In the absence of as-yetunidentified GSL sugar modifications, these results indicate that GlcCer itself exerts the polarity effect, for which additional sugar modifications are dispensable.
Finally, our mass spectrometry analysis characterized GlcCer as invariably hydroxylated, consistent with the identified sphingolipid fatty-acid hydroxylase, C25A1.5, and containing a saturated LCFA of C21-C26 chain length, with C22 in greatest abundance (Fig. 7e) .
We conclude that the polarity-affecting lipid compound is probably GlcCer-OH itself, with or without specific sugar modifications, with a C17 branched-chain LCB and a saturated LCFA of length C21-C26, probably C22 (Fig. 7e, inset) .
GSL biosynthesis affects vesicular trafficking
GSLs localize to endothelial vesicle membranes and lumenal plasma membranes, are synthesized on vesicle membranes and apically sort several membrane molecules in mammalian epithelial cell lines 8, 14, 41 . Feeding partially rescuing BODIPY-C5-Cer and NBD-C6-GlcCer indicated that both lipids also localize to vesicles and the lumenal membrane of the C. elegans intestine (Fig. 8a) .
Consistent with a conserved GSL trafficking function were the following findings: low-temperature interference with trafficking suppressed the polarity conversion, indicating that vesicular transport was required to reveal the misdirection of apical membrane components ( Fig. 8b and Supplementary Fig. S8a-g ; note, low temperature also slows growth and development); sptl-1(RNAi) intestinal sections revealed vesicle paucity, along with distended endoplasmic reticular and Golgi membranes ( Fig. 8c and Supplementary Fig. S8h,i) ; the pod-2-, let-767-, acs-1-, sptl-1(RNAi) and cgt-1(tm999)/cgt-3(RNAi)-induced polarity conversion depleted intestinal endosomes, primarily RAB-11-associated, presumed lumenal-membrane-forming vesicles 4, 42 ( Fig. 8d, not shown) . RAB-11-positive vesicles were first slightly enlarged, then lost from the apical membrane; RAB-5-associated early endosomes were occasionally mildly enlarged subapically; L1-specific RAB-7-positive apical clusters, but not the presumed Golgi-associated mid-cytoplasmic endosomes, were decreased in number or absent; RAB-10-associated basolateral recycling endosomes were least affected 43 . α-mannosidase II (MANS) -associated Golgi membranes, distributed as mini-stacks throughout the wild-type C. elegans cytoplasm 43, 44 , contracted basolaterally, assuming a linear, possibly tubulated, pattern (Fig. 8d) .
Finally, BODIPY-C5-Cer and NBD-C6-GlcCer, which only mildly improve polarity defects, were themselves displaced to lateral ectopic lumens in sptl-1(RNAi) and cgt-1(tm999)/cgt-3(RNAi) intestines (Fig. 8e) , demonstrating that GSL biosynthesis also affects the targeting of lipids, including its own apical placement. Given the membrane association of GSLs, this finding further supports a function of GSL biosynthesis in the vesicular delivery of apically destined molecules during membrane biogenesis. 
DISCUSSION
The long-proposed essential role of GSLs in development has remained mysterious, and their postulated contribution to in vivo polarity uncertain 14, 19, 45, 46 . Here, an unbiased genetic tubulogenesis screen uncovers an essential role for GSLs in maintaining polarity and a central lumen in the developing C. elegans intestine. Our analysis indicates that endo-and plasma-membrane-associated GSLs determine polarity by sorting new components to expanding apical membranes: their loss simultaneously decreases molecular and structural apical characteristics at original apical membranes while increasing them at original lateral membranes; this polarity conversion diverts newly synthesized membrane components from their apical path; it requires cell growth and trafficking, but not cell division, migration or junction disassembly; it is reversible in single cells on restoration of lipid biosynthesis; it depletes apical endosomes, including RAB-11-associated lumenal vesicles; and it affects the presumed membrane-associated apical delivery of GSLs themselves. Without excluding additional GSL roles in structural membrane biogenesis or other trafficking aspects, an apical sorting function is strongly supported by the documented ability of GSLs to apically deliver several molecules in mammalian cell lines 8, 11, 12, 15 . Our findings in turn now provide evidence for the relevance of these in vitro findings for polarized tissue morphogenesis in vivo, and for the proposition that GSLs may determine apical plasma membrane domain identity 47 . GSLs, similarly to phosphoinositides, may combine aspects of both endo-and plasma-membrane-based polarity cues, suggesting a mode of integration for these distinct membrane-associated polarity determinants 2 . Phosphoinositides, classical vesicle-based sorting signals 9 , do, in fact, control plasma membrane domain identity and affect mammalian tubulogenesis in vitro 5, 48, 49 . Previously characterized core polarity determinants of developing epithelia, such as the Par-, Crumbs-and Scribble-related protein complexes, were characterized in proliferating and migrating cells or cell populations 2, 3, 7 . Our in vivo single-cell analysis of post-mitotic expanding epithelia, which separated membrane biogenesis from proliferation-and migration-dependent polarity cues, may have allowed the identification of the innate sorting ability of these structural membrane lipids during de novo membrane biogenesis. This analysis also revealed unanticipated aspects of polarity and tissue plasticity: polarity remains dynamic in single post-mitotic cells; the lumen position is flexible in a fully constructed tube epithelium; and both polarity and lumen position can be reversibly shifted on the growing membrane in situ by lipid-biosynthesis modulation.
The sorting function of GSLs in mammalian cell lines was linked to the formation of rafts, thought to form on lumenal vesicle-and plasmamembrane leaflets 10, 50, 51 . However, GlcCer, the GSL backbone without sugar modification, is uniquely placed on cytoplasmic membrane leaflets, a location distinct from its derivatives and of unknown significance 14 . Here it may directly interact with apically destined cytoplasmic molecules, polarity determinants or coat complexes. Intriguingly, loss of tat-2, the gene encoding a C. elegans flippase that vertically translocates lipids between membrane leaflets, rescues the lethality of sptl-1 and mmBCFA loss 52 . If TAT-2 were to flip GlcCer to the lumenal leaflet, its loss would increase GlcCer at the cytoplasmic leaflet where it could improve apical transport. A GSL-specific flippase was postulated, but has not yet been identified 14, 17 .
Whereas GlcCer sugar modifications are deemed critical for sorting in mammalian cell lines 8 (a finding so far not confirmed by targeted deletions of the genes encoding their biosynthetic enzymes in mice 19 ), we found them dispensable for tubular polarity in vivo. The vertebrate-and invertebrate-specific lacto-and arthro-series of GlcCer-derivatives can be swapped in Drosophila for developmental functions 53 , indicating tolerance for sugar modifications, emphasizing the importance of the sphingolipid backbone, and further supporting its interspecies conserved function. In intriguing agreement with our findings, epithelial polarization in mammalian cell lines was recently linked to GSL glycans 54 , and to an sphingomyelin-to GSL-biosynthesis switch, with an increase in GSL fatty-acid length, saturation and hydroxylation 55 . GlcCer (or GlcCer-OH), as part of complex GSLs, may also affect sorting through lipid-lipid-microdomain or lipid-proteinshell formation on lumenal membrane leaflets 18, 50, 51 . Our finding that GSL biosynthesis positions the apical domain during de novo membrane biogenesis is unexpectedly consistent with the original, but subsequently abandoned, proposition that GSLs segregate the apical plasma membrane through endomembrane maturation during bulk membrane biogenesis 16 . The dose-dependent effect of GSLs on polarity and the rescue of moderate GSL-dependent polarity defects by growth restriction indicate that the relative proportions of GSLs may be critical for polarized membrane biogenesis. The dependency of the apical placement of GSLs on their own biosynthesis is consistent with a requirement for their endomembrane-associated synthesis, a scenario compatible with the proposed polarizing component of membrane biogenesis by lipid-based self-organization 16 . Despite known functions in polarized morphogenesis in vitro 48, 49 , lipids escaped identification in numerous genetic polarity screens. Lipid-biosynthetic enzymes identified in genetic screens are often not pursued because they typically synthesize multiple compounds. Here we show that systematic biosynthetic pathway targeting, combined with genetic interaction studies, can identify an end-point biosynthetic enzyme, and thus a lipid species. Along with defining biosynthesis pathways (here, the C. elegans sphingolipid biosynthesis pathway), this approach can identify multiple proteins directly controlling a function of interest (here, eleven lipid-biosynthetic enzymes directly regulating tubular polarity), and may reveal functions of intermediates (here, the role of the enigmatic mmBCFAs in tubular polarity). Notably, the simultaneous generation of multiple loss-and gain-of-function conditions for downstream products and upstream substrates, respectively, inherent to this approach, helps distinguish primary from secondary changes, a particular conundrum of lipid analysis where intermediates are interconverted and compensatory changes frequent 56 . The additional biosynthetic screen for sugar modifications demonstrated that an identified lipid species can be further defined as a chemical compound and indicates that such screens can also be used for the analysis of sugars. This approach should be generally applicable to extend the power of unbiased genetic screens to non-proteinaceous compounds, identifying their in vivo cellular roles beyond known metabolic functions.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology Design of the global C. elegans tubulogenesis screen. To investigate multicellular tube/intercellular lumen formation and single-cell tube/intracellular lumen formation, we examined intestinal (multicellular) and excretory canal (single-cell) morphogenesis. Both tubular systems form during mid-embryogenesis and in early larvae. To also identify essential early acting genes (maternal-effect lethal genes and maternal-effect/embryonic lethal genes) whose earlier action may mask a later function in tube development, we chose an RNAi screen that targets both maternal and zygotic RNAs and generates a spectrum of mild to severe phenotypes. The visual screen was carried out using animals with ERM-1::GFP-labelled membranes that outline the lumens of the intestine, the excretory canal and the gonad 57 . Each knockdown was evaluated throughout development under a dissecting microscope equipped with a high-power stereo fluorescence attachment, and special attention was given to embryos and larvae (screen results will be reported separately; H.Z. and V.G., manuscript in preparation).
In pilot screens, we found that a wild-type background identified a higher ratio of informative tube defects to general morphogenesis defects than an RNAi-sensitive background (see below, RNAi and screens). We thus chose a moderately severe reduction-of-function RNAi analysis (defined here as 'standard' RNAi conditions), which proved efficient at re-isolating genes previously shown to affect tubulogenesis, including very early acting intestinal transcription factors such as the Wnt pathway component pop-1.
Among essential genes, 216 RNAi-mediated knockdowns generated tube defects immediately separable from additional morphogenesis changes. Using complementing apical and basolateral membrane markers and confocal microscopy, the intestinal tube defects were further separated into distinct phenotypic classes affecting different aspects of tube and lumen formation. They could be divided into two basic groups with regard to their effect on ERM-1::GFP placement (with or without displacement). Lipid-biosynthetic enzymes were exclusively identified in the class of tube defects that resulted in basolateral misplacement of ERM-1::GFP.
RNAi and screens. RNAi was carried out by feeding RNAi bacteria (Escherichia coli
HT115), containing plasmid vectors that transcribe the specific DNA sequence being targeted in both directions, generating double-stranded RNA (dsRNA) on induction of the bacterial polymerase by isopropylthiogalactoside (IPTG), as described previously 64 . Briefly, RNAi bacteria were cultured in Luria broth containing 50 µg ml −1 ampicillin for 8-18 h at 37 • C and spotted onto nematode growth media (NGM) agar plates containing 50 µg ml −1 carbenicillin, and 2 mM IPTG for dsRNA induction at room temperature (RNAi plates).
For the genome-wide RNAi screens, bacterial clones were derived from the Ahringer genome-wide RNAi feeding library representing ∼16,800 genes (J. Ahringer, Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK). The lethal RNAi library was replicated from a collection of clones derived from the Ahringer library and the Vidal ORFeome-based RNAi library that had previously shown either embryonic, larval or adult arrests or sterility in a wild-type or RNAi-sensitive (eri-1(mg366)) background 65 . Specific clones for the subsequent targeted lipid-biosynthetic pathway screens were selected from the Ahringer library. To compile these separate libraries, the literature was searched for previously studied C. elegans genes involved in biosynthesis, metabolism and transport of fatty acids, complex lipids and, in particular, sphingolipids, as well as for genes involved in lipid glycosylation. The search results were combined with BLAST searches for C. elegans homologues of such genes that had been identified in other organisms, including yeast, Drosophila and vertebrates/humans.
For the screens, eggs were isolated from gravid hermaphrodites and embryos were allowed to hatch overnight in the absence of food. The thus synchronized L1 larvae were placed on agar plates seeded with E. coli OP50 and allowed to further develop to L3-L4-stage larvae. After washing, ∼5 animals were dispensed on each RNAi plate and allowed to produce progeny for 60-72 h at room temperature. For each RNAi clone, the progeny of synchronized L4 animals (generally > 500 animals) was examined for morphological defects on 6-well agar plates with a dissecting microscope equipped with a high-power fluorescence attachment (see below, Dissecting fluorescence and confocal microscopy). A spectrum of phenotypes and stages, including embryos, was analysed at different time points for each clone. In all experiments, act-5 RNAi (resulting in ∼100% L1 lethality by its effect on the intestine), unc-22 RNAi (resulting in a twitching phenotype by its effect on muscle) and/or DsRed RNAi (mock, not generating a phenotype) were included to control for efficient RNAi induction in the intestine and for potential unspecific RNAi effects. Experiments were carried out in duplicate or triplicate, and, when positive, additional sets under different screening conditions were added. Plasmids of positive clones or clones producing unexpected results were sequenced to confirm the identity of the plasmid.
For single RNAi experiments, animals were hand-picked and scored during the development of the first or second generation and transferred to fresh RNAi plates after two days, as needed. Polarity phenotypes induced in the erm-1::gfp transgenic strain were confirmed in N2. Standard RNAi conditions, as used for the screens, were defined as using wild-type animals fed with RNAi clones induced with 2 mM IPTG. Strong RNAi conditions used the RNAi-sensitive strains eri-1(mg366), rrf-3(pk1426) or eri-1(mg366);lin-15B(n744) under the same conditions. Mild RNAi conditions were empirically determined for each clone by titrating IPTG concentrations over a wide range of concentrations down to 2 × 10 −12 mM and by diluting RNAi bacteria with control RNAi bacteria. For double RNAi, equal amounts of RNAi bacteria of two different clones were mixed. Conditional RNAi was induced by placing untreated eggs or young adults on RNAi plates under standard conditions and evaluating that same generation for either larval or adult RNAi effects, respectively.
DsRed feeding. The HT115 RNAi feeding strain, containing a plasmid constitutively expressing DsRed, produces faint red colour. When fed to wild-type animals only the intestinal lumen is labelled, whereas when fed to animals with membrane or junction integrity defects, the intestinal cells and/or intracellular spaces are also labelled. In feeding experiments, DsRed bacteria were mixed 1:1 with RNAi bacteria containing plasmids targeting the different lipid-biosynthetic enzyme genes. This mixture did not affect the generation of severe phenotypes.
Feeding of sphingolipid biosynthesis inhibitors.
Eggs collected from wild-type gravid hermaphrodites were placed onto plates seeded with E. coli OP50 or mock RNAi bacteria mixed with inhibitors or solvent control, and observed for phenotype development. Stock solutions were generated of 2 mg ml −1 myriocin (Sigma) in methanol, 25 mg ml −1 fumonisin (BioMol) in water, 80 mg ml −1 N -(n-butyl) deoxygalactonojirimycin (C 4 DGJ, Toronto Research Chemicals (TRC)) in water, 10 mg ml −1 N -(n-nonyl) deoxygalactonojirimycin (C 9 DGJ, TRC) in methanol, 100 mg ml −1 N -butyldeoxynojirimycin hydrochloride (C 4 DNJ, TRC) in water, and 100 mg ml −1 d,l-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol·HCl (PDMP, MATREYA) in ethanol and further diluted as needed. Equal volumes of different concentrations of inhibitors and solvents (control) were mixed with bacteria, with some precipitation of myriocin occurring because of its water insolubility.
Phenotype reversal. For phenotype reversal, adults treated with fatty-acidbiosynthetic enzyme RNAi under standard conditions were transferred to plates containing either E. coli OP50 or mock RNAi bacteria, allowed to lay eggs for 1-2 h and then removed. Progeny that did not develop the polarity phenotype after 24 h were removed from the plates. Remaining larvae with phenotypes were analysed at different time points for three days. No case of spontaneous reversal was observed with continued lipid biosynthesis depletion under any condition (N > 1,000).
For phenotype reversal under conditions of sphingolipid biosynthesis restriction, hermaphrodites treated with pod-2-, acs-1-or let-767 RNAi under standard conditions were allowed to lay eggs on plates containing sptl-1 RNAi bacteria, mycotoxins or both. Larvae with phenotypes were selected for analysis. Conditions of decreased sphingolipid biosynthesis were titrated to prevent induction of the phenotype on their own. For the experiments shown, standard RNAi conditions were used for sptl-1 with and without 10 µg per plate of fumonisin B1. Animals were analysed and counted in parallel to animals reversing on mock RNAi control plates.
Phenotype suppression by starvation and cold temperature. For starvation experiments, eggs collected from bleached gravid mutant or RNAi hermaphrodites were placed onto either empty plates or plates seeded with E. coli OP50 and compared for phenotype, size and developmental stage. For temperature experiments, eggs from mutant hermaphrodites were placed on OP50 plates and eggs from RNAi hermaphrodites were place on corresponding RNAi plates. These were kept at either 12 • C or 22 • C and compared for phenotype development and stage. Wild-type animals were grown in parallel to controls for developmental delay at cold temperature. For experiments using let-767 dpy-17 mutant animals, Dpy animals were picked and transferred to corresponding plates with or without OP50 at 12 • C or 22 • C.
Rescue by fatty-acid and sphingolipid supplementation and localization of labelled exogenous sphingolipids. For both mutant and RNAi rescue, L4 larvae were grown on plates spotted with a mixture of fatty acids or sphingolipids with solvent/carrier and E. coli OP50 or RNAi bacteria. Progeny were evaluated for reversion to the wild type or improvement of the polarity defect at different time points, as indicated.
For labelling wild-type animals, embryos, larvae and adults were grown on E. coli OP50 spiked with labelled lipids for different time periods (12 h, unless indicated otherwise), removed from lipid-containing plates and fed with non-supplemented bacteria (for 2 h, unless indicated otherwise). Live animals were analysed by DOI: 10.1038/ncb2328
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dissecting fluorescence microscopy and confocal imaging for cellular and subcellular localization of the exogenous lipids. For labelling RNAi animals, standard RNAi was carried out with RNAi bacteria spiked with labelled lipids, and the progeny was analysed as described above.
For the fatty-acid rescue experiments shown, 20 mg ml −1 stock solutions of palmitic acid (Sigma) were prepared in ethanol and used at a concentration of 10 µl per 120 µl of bacteria per plate. Stock solutions (400 mM) of the monomethyl branched-chain fatty acids (mmBCFAs) iso-C15 and iso-C17 (Sigma) were prepared in dimethylsulphoxide (DMSO), diluted 200-fold in 1 mM fatty-acid-free BSA and used at a concentration of 15 µl per 120 µl of bacteria per plate. Equal volumes of fatty-acid mixtures and lipid-free solvent/carrier controls were used in all experiments.
For sphingolipid rescue experiments, a sphingolipid internal standard mixture (Avanti Polar Lipids) containing 25 µM each of ten compounds (C17-sphingosine ( (2S, 3R, 4E)-2-aminoheptadec-4-ene-1,3-diol), C17-sphinganine ((2S, 3R)-2-aminoheptadecane-1,3-diol) ), C17-sphingosine-1-phosphate (heptadecasphing-4-enine-1-phosphate (ammonium salt)), C17-sphinganine-1-phosphate (heptadecasphinganine-1-phosphate (ammonium salt)), C12-ceramide (N -(dodecanoyl)-sphing-4-enine), C25-ceramide (N -(pentacosanoyl)-sphing-4-enine), C12-ceramide-1-phosphate (N -(dodecanoyl)-sphing-4-enine-1-phosphate (ammonium salt)), C12-sphingomyelin (N -(dodecanoyl)-sphing-4-enine-1-phosphocholine), C12-GlcCer (N -(dodecanoyl)-1-β-glucosyl-sphing-4-eine) and C12-lactosylceramide (N -(dodecanoyl)1-β-lactosyl-sphing-4-eine)) dissolved in ethanol was used at a concentration of 40 µl per 120 µl of bacteria per plate.
For GSL rescue, plates seeded with 120 µl of bacteria mixed with 5 µl of a 10 mM stock solution of C12-GlcCer ((N -(dodecanoyl)-1-β-glucosyl-sphing-4-eine), Avanti Polar Lipids) dissolved in ethanol were used. For both labelling and rescue experiments, plates were prepared by mixing 120 µl of bacteria with 5 µl of a 5 mM stock solution of BODIPY-FL-labelled C5-ceramide (N -(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)sphingosine; Invitrogen)-BSA complexes dissolved in sterile deionized water, or 100 µM NBD-C6-GlcCer (N -(6-((7-nitro-2-1,3-benzoxadiazol-4-yl)amino)hexanoyl)-d-glucosyl-ß1-1 -sphingosine; Avanti Polar Lipids) dissolved in ethanol.
Genetic interactions. To examine genetic interactions between different lipid-
biosynthetic enzyme mutants/RNAi animals, milder RNAi conditions were empirically determined by diluting IPTG and RNAi bacteria until a penetrance of 0-50% was achieved. RNAi conditions used ranged from very mild to standard. For the experiments shown, wild type and let-767(s2819);sDp3 animals carrying the erm-1::gfp transgene were placed on RNAi plates containing 2×10 −12 mM IPTG and a 2:1 mixture of control and sptl-1 and pod-2 RNAi bacteria, and on undiluted cgt-1; cgt-3 RNAi bacteria using standard conditions. Plasmids and DNA transformation. To obtain translational GFP fusion proteins, DNA including the promoter and full-length coding sequence of the gene of interest was amplified from genomic DNA by the polymerase chain reaction (PCR; Expand Long Template or Expand High Fidelity PCR Systems from Roche Molecular Biochemicals) and joined in frame with the GFP coding sequence terminated by the 3 − UTR of the gene in the previously modified plasmid vector pPD95.75 (A. Fire, S. Xu, J. Ahnn and G. Seydoux, personal communication) by the stitching method 66 . DNA was prepared from multiple independent isolates, verified by restriction digest and sequencing, and a mixture was used for germline transformation of animals by microinjection 67 . Constructs were injected at 10-100 ng ml −1 , along with appropriate selection markers. At least three independent transgenic lines were generated for each construct. Sequences of oligonucleotides that were used for various recombinant procedures and PCR experiments are available on request.
Antibodies and immunofluorescence staining. Animals were collected in M9 on slides coated with high-molecular-weight polylysine (Sigma), covered with coverslips overhanging the edge of slides, and permeabilized by flash-freezing in liquid nitrogen and flicking off the coverslip, as previously described 68 . Fixation was carried out by sequential incubation in methanol and acetone at −20 • C or using 4% paraformaldehyde at room temperature. Primary and secondary antibodies were used at the following concentrations: MH27 (anti-AJM-1), 1:20; anti-DLG-1, 1:10; MH33 (anti-IFB-2), 1:20; MH46 (anti-myotactin), 1:100 (all Developmental Studies Hybridoma Bank, University of Iowa); ICB4, 1:500 (gift from M. de Bono, Laboratory of Molecular Biology, Cambridge University, UK); mouse anti-actin, 1:100 (Sigma); Alexa Fluor 568 phalloidin (actin), 1:20 (Molecular Probes); FITC-conjugated goat anti-mouse IgG, 1:100 (Sigma); TRITC-conjugated goat anti-mouse IgG, 1:100 (Sigma); Cy5-conjugated goat anti-mouse IgG, 1:250 (Jackson Immunoresearch).
Dissecting fluorescence and confocal microscopy. For live-specimen analysis, animals were either directly observed on plates under a dissecting fluorescence microscope or mounted on glass slides and immobilized using 10 mM sodium azide (Sigma) for confocal and Nomarski analysis.
Fluorescence dissecting images were obtained using an Olympus SZX12 microscope (Olympus America) equipped with a custom-made high-power stereo fluorescence attachment (Kramer Scientific Corporation) and a digital CCD (charge-coupled device) camera (Qimaging RETIGA 2000R) and Qcapture software (Qimaging). Confocal images were acquired on a Leica TCS SL laser-scanning microscope (Leica Microsystems). Single-plane images were taken as 6-50 sections along the z axis at 0.2 µm intervals. For confocal z series, section images were merged into a single projection image. Multi-channel images were taken after adjusting individual channels to eliminate bleed-through or sequentially scanned. Images were taken at minimal laser settings unless indicated otherwise. Identical laser and confocal settings were used when comparing experimental animals with controls (for example, for the analysis of vesicle populations). Images were arranged using Adobe Photoshop with occasional small adjustments for contrast and brightness (blue label brightness was increased throughout).
TEM. TEM procedures were carried out according to the general procedures described previously 69 . RNAi L1 larvae were collected from ∼15 plates per experiment and fixed in 2.5% glutaraldehyde and 1.0% paraformaldehyde in 0.05 M sodium cacodylate buffer, at pH 7.4, plus 3.0% sucrose. The cuticles were 'nicked' with a razor blade in a drop of fixative under a dissecting microscope to allow the fixative to penetrate. After 1 h fixation at room temperature, the worms were fixed overnight at 4 • C. After several rinses in 0.1 M cacodylate buffer, the samples were post-fixed in 1.0% osmium tetroxide in 0.1 M cacodylate buffer for 1 h at room temp. They were rinsed in buffer and then in double-distilled water and stained, en bloc in 2.0% aqueous uranyl acetate for 1 h at room temperature. After rinsing in distilled water, worms were embedded in 2.0% agarose in PBS for ease of handling. The agarose blocks were dehydrated through a graded series of ethanol to 100%, then into a 1:1 mixture of ethanol/EPON overnight on a rocker. The following day, the agarose blocks were further infiltrated in 100% EPON for several hours and then were embedded in fresh EPON overnight at 60 • C. Thin sections were cut on a Reichert Ultracut E ultramicrotome and collected on formvar-coated gold grids. They were post-stained with uranyl acetate and lead citrate and viewed using a JEOL 1011 TEM at 80 kV equipped with an AMT digital imaging system (Advanced Microscopy Techniques).
Sphingolipid extraction and liquid chromatography-mass spectrometry.
RNAi was carried out on 10 cm agar plates, and arrested L1-stage RNAi larvae were collected after removal of parents by picking all adult animals off the plates. For each gene, the contents of ∼800 plates were collected by rinsing the RNAi plates with M9 buffer and letting animals sediment at 4 • C, resulting in a final volume of about 200 µl worm pellets per knockdown. As controls, equal amounts of synchronized wild-type L1 larvae, grown on the same bacterial strain (E. coli HT115), were collected. Worm pellets were subjected to three cycles of freezing in liquid nitrogen and thawing followed by sonication. The suspension was lyophilized for measurement of dry weight. Lipid extraction was carried out in the presence of pre-spiked internal standards with 2:1 methanol and chloroform at 48 • C for 24 h followed by 15 min sonication at 37 • C, as described previously 70 . After solvents were evaporated under nitrogen at room temperature, the samples were digested by 1 M KOH in methanol at 37 • C for 2 h to recover ceramides and sphingoid bases, and then neutralized with glacial acetic acid. The resulting samples were back-extracted with chloroform and the final chloroform layer was clarified with drop-wise methanol and reconstituted to a final volume of 1 ml with a 9:1 mixture of liquid chromatography-mass spectrometry (LC-MS) mobile phases A ((97:2:1 ACN/CH 3 OH/CH 3 COOH) + 5 mM NH 4 OAC) and B ((99:1 CH 3 OH/CH 3 COOH) + 5 mM NH 4 OAC) for analysis. LC-MS analysis was carried out on an ABI 4000 Q trap mass spectrometer interfaced to a Dionex U3000 liquid chromatograph equipped with an Astec NH2 4.5 X 150 mm, 5u column. Lipids were eluted using the following gradients: 100% solvent A for 2 min, a gradient from 0% B to 100% B in 14 min and 100% B for 15 min. For mass spectrometry, the ion spray voltage was set to 4,500 V, the temperature was set to 400 • C and the gas pressure was set Fig.1d ; view here from posterior left lateral aspect). Apical junctions are shown, placed at apicolateral margins, surrounding and sealing the lumen between adjacent cells (black bars, compare Fig.1a) . One electron dense unit covers both adherens-(apically placed) and tight/septate (basally placed) functional junction subunits 20 . After intercalation in mid-embryogenesis, no further cell division or migration occurs, but the epithelium expands during late embryogenesis and four larval stages (L1 -L4) 71 . Cell growth occurs continuously from the L1 stage onward, following a linear pattern during each larval stage that continues into the adult, assuming an exponential curve in molting larvae that flattens out in adults 21 . Fig.1b/3a] ). Lethality is >90% for all knockdowns at standard RNAi conditions (shown here, except for pod-2; Methods), with early larval lethality and a >90% penetrant tubulogenesis phenotype for let-767-, acs-1-and sptl-1(RNAi) (N>500). pod-2(RNAi) causes embryonic lethality with a lower penetrant tubulogenesis phenotype (~50%, phenotype development probably masked by the earlier lethality; The basolaterally enriched submembraneous ERM-1-family member NFM-1 57 retains its basolateral location in RNAi animals, but also collects in the sub-apical zone (an nfm-1::gfp construct with a punctate panmembraneous expression pattern is shown here). (e) The apical junction component DLG-1/ Discs-Large 74 maintains its contiguous apical ladder pattern (arrows), but additionally surrounds lateral ectopic lumens in lipid-biosynthetic-enzymedepleted animals (arrowheads). (f -g) The anti-AJM-1-labeled apical junction belt remains intact (arrows), although expanded around ectopic lumens (arrowheads), while apical PAR-6 is displaced to the cytoplasm (f) and ERM-1 (g) to lateral membranes and cytoplasm in RNAi animals. Confocal images of representative L1 intestines are shown in a -g (RNAi animals at stage of lateral lumen development; N>20). (h) TEM cross-sections of whole L1 intestines (top) with corresponding higher magnifications (bottom). Early ectopic lumen (EL) formation is shown, with multiple small lumens emerging along the lateral membrane in RNAi animal, surrounded by additional ectopic junctions that appear ultrastructurally normal. Large single lateral lumens arise at later stages of phenotype development, consistent with a possibly transient nature of these ectopic junctions (Fig.1b, lower right image) . Serial sections in selected areas failed to reveal any ectopic lumens that were not either directly or indirectly (via other ectopic lumens) in contact with a lateral membrane. Intestinal plasma membranes are outlined for clarity; L, main apical lumen. . Phenotype penetrance correlates with inhibitor concentration (bottom panels), consistent with its correlation with RNAi strength and allele severity in fatty-acid-biosynthetic-enzyme-depleted animals (Fig.4b) . Note that the polarity phenotype was induced on the expanding membranes of animals hatched on mycotoxin containing plates (parents were grown on OP50 Data Table- Wild type
